Certain postmortem case constellations require intensive investigation of the pattern of drug use over a long period before death. Hair analysis of illicit drugs has been investigated intensively over past decades, but there is a lack of comprehensive data on hair concentrations for antidepressants, antipsychotics, and benzodiazepines. This study aimed to obtain data for these substances. A LC-MS/MS method was developed and validated for detection of 52 antidepressants, antipsychotics, benzodiazepines, and metabolites in hair. Hair samples from 442 postmortem cases at the Institute of Legal Medicine of the Charité-University Medicine Berlin were analyzed. Postmortem hair concentrations of 49 analytes were obtained in 420 of the cases. Hair sample segmentation was possible in 258 cases, and the segments were compared to see if the concentrations decreased or increased. Descriptive statistical data are presented for the segmented and non-segmented cases combined (n = 420) and only the segmented cases (n = 258). An overview of published data for the target substances in hair is given. Metabolite/parent drug ratios were investigated for 10 metabolite/parent drug pairs. Cases were identified that had positive findings in hair, blood, urine, and organ tissue. The comprehensive data on postmortem hair concentrations for antidepressants, antipsychotics, and benzodiazepines may help other investigators in their casework. Postmortem hair analysis results provide valuable information on the drug intake history before death. Pattern changes can indicate if drug intake stopped or increased before death. Results should be interpreted carefully and preferably include segmental analysis and metabolite/parent drug ratios to exclude possible contamination.
Introduction
The detection and quantification of drugs of abuse in hair has been the focus of research over the last three decades [1, 2] . It is well-known that intra-and inter-individual differences, hair pigmentation [3] , and hair cosmetics [4] have major impacts on the results of these analyses [2, 5] . Therefore, such results are always interpreted with great care, and this can provide valuable retrospective insight into the pattern of consumption [5, 6] . Currently, scientists can evaluate, to a certain degree, how often a person was exposed to or consumed a certain drug within recent months. This enables widespread application of hair analysis in postmortem toxicology [7, 8] , workplace drug testing, and abstinence control programs [2, 9] .
There has been extensive research on the detection of all kinds of drugs in hair, and the idea that hair concentrations could be correlated to the dose taken is of particular interest [10, 11] . However, after initial research provided insight on inter-individual differences, research on substances other than drugs of abuse has decreased somewhat. Quantitative data from hair analyses for these substances are published in case reports [12, 13] or studies with only a small number of subjects [14] [15] [16] [17] [18] [19] [20] [21] [22] . There have been few comprehensive studies with large populations or investigations of a wide range of substances [23, 24] .
Antidepressants and antipsychotics are commonly found in postmortem toxicology [25] because of their high prescription rates and relatively high toxicities in overdose situations. Because of the limited data for such substances, results from hair analyses in these cases are hard to interpret. Segmental analyses can help provide more information about changes in drug intake [16, 17, 26] , but more quantitative data from hair analyses is needed for comparison and interpretation. The aim of this research was to expand the knowledge base of concentrations of antidepressants, antipsychotics, and benzodiazepines in postmortem hair samples.
First, a LC-MS/MS method was developed and validated for the detection of 52 substances (antidepressants, antipsychotics, and benzodiazepines) according to the guidelines of the German Society of Forensic Toxicology (GTFCh) [27, 28] . Then, within an observational study, hair samples from 442 postmortem cases were analyzed with this method. Overall, quantitative data from 420 postmortem cases was obtained. Descriptive statistical data and the importance of careful interpretation of results from postmortem hair analyses are discussed.
Material and Methods

Reagents and Chemicals
Sample preparation was performed with analytical grade solvents obtained from Merck KGaA (Darmstadt, Germany). LC-MS grade acetonitrile for the mobile phase was obtained from Fisher Scientific GmbH (Schwerte, Germany), and water and formic acid (99% purity) were purchased from Acros Organics (Geel, Belgium). The following deuterated standards (99% purity) were purchased from LGC Standards GmbH (Wesel, Germany): 6-monoacetylmorphine-d 3 , alphah y d r o x y a l p r a z o l a m -d 5 , a l p r a z o l a m -d 5 , 7aminoflunitrazepam-d 7 , amphetamine-d 5 , benzoylecgonined 5 , buprenorphine-d 4 , clonazepam-d 4 , cocaine-d 3 , cocaethylene-d 3 , codeine-d 3 , diazepam-d 5 , dihydrocodeined 3 , 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine-d 3 , flunitrazepam-d 7 , fentanyl-d 5 , ketamine-d 4 , lorazepam-d 4 , methamphetamine-d 5 , 3,4-methylenedioxyamphetamine-d 5 , 3,4-methylenedioxy-N-ethylamphetamine-d 6 , 3,4methylenedioxy-N-methylamphetamine-d 5 , methadone-d 9 , methylecgonine-d 3 , morphine-d 3 , nordazepam-d 5 , norbuprenorphine-d 3 , norcocaine-d 3 , nortilidine-d 3 , oxazepam-d 5 , oxycodone-d 3 , tilidine-d 6 , temazepam-d 5 , and tramadol-d 3 . A standard mixture containing 1 ng/μL of each antipsychotics, and stimulants. From that list, the substances shown in Table 1 were selected as analytes of interest. In contrast to other regions, for example, the USA, all these substances were marketed and prescribed in Germany in 2015.
Characteristics of Chromatography, Internal Standards, Transitions, and Retention Times
The MRM mass transitions were manually optimized for each substance. Next, the mobile phase gradient was optimized with regard to acceptable separation of the target from matrix components. Table 2 summarizes the main MRM transitions, retention time, and corresponding internal standard for each substance. A mixture of water containing 0.1% formic acid (eluent A) and acetonitrile (eluent B) was used as the mobile phase for gradient elution over 18 min as follows: start, 7% B; 0-8 min, 30% B; 8-14 min, 35% B; 14-16 min, 40% B; and 16-17 min, 7% B (starting condition). The flow rate was set to 0.4 mL/min, and the injection volume was 5 μL. The column temperature was 40°C. In addition, the source parameters were optimized to the following settings: drying gas at 250°C with a flow rate of 10 L/min, sheath gas at 380°C with a flow rate of 12 mL/min, nebulizer pressure of 25 psi, and capillary voltage of 4500 V. A dynamic detection mode (dynamic MRM) was used to increase the sensitivity, reproducibility, and precision of the 247 mass transitions. Because the minimum cycle time was 432.0 ms with a maximum of 32 concurrent transitions, the cycle time was set at 500 ms, resulting in a minimum dwell time of 12.13 ms.
Method Validation
The method validation followed the protocol in the guidelines of the GTFCh [27, 28] . Six different blank hair specimens with and without the internal standard were first tested to prove the selectivity of the method. Then, a calibration range between 0.005 and 2.5 ng/mg was tested with spiked blank hair samples that were injected six times. Next, the limit of detection and lower limit of quantification (LLOQ) were estimated following the protocol of the German standard DIN 32645 [31] . The accuracy was tested with hair samples spiked at a low concentration (0.03 ng/mg) and a high concentration (1 ng/mg) over 5 days. The same concentration levels were prepared to assess the stability of analytes in processed samples that were stored in the autosampler for 77 h. Furthermore, five different hair specimens were spiked at the same concentration levels before extraction and after extraction to test matrix effects and the recovery.
Observational Study of Postmortem Cases
Case Selection
The main aim of this study was to obtain comprehensive data on a wide range of psychoactive drugs. Effective preselection of cases was important to detect as many positive cases as possible. As a starting point, postmortem cases from 2012 to 2015 with positive results for antidepressants and antipsychotics in blood, urine, or organ tissue were identified [25] MDEA 3,4-methylenedioxy-N-ethyl-amphetamine, EDDP 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, MDMA 3,4methylenedioxymethamphetamine, MDA 3,4-methylenedioxy-amphetamine in a retrospective cross-sectional study. Furthermore, cases with a mention of the substances of interest in the prosecutor's file were identified. Hair samples taken during autopsy were not available in all cases. In total, hair samples from 442 cases were prepared, segmented if possible, and analyzed with the validated method. Aggressive hair treatment like bleaching, coloration, or dyeing is known to reduce the amount of a drug incorporated into hair [4] . In our study, there was no information available on hair cosmetics. Therefore, a bias might be created by including cosmetically treated hair samples. To reduce further bias from differences in hair growth, only cases where head hair was available were included.
Results
Method Validation
The method had sufficient selectivity and showed no interfering or co-eluting signals in the chromatogram. It was then successfully validated according to the described guidelines [27, 28] and fulfilled all requirements for selectivity, accuracy, stability, matrix effects, and recovery. Figure 1 summarizes the linear range, limit of detection, LLOQ, and accuracy data for each analyte. The LLOQ range was 1.2-37 pg/mg and showed the method had good sensitivity. Mandel's F-test for linearity and the Cochran test for homogeneity of variance were used to show the calibration curve was linear between 0.005 and 0.05-2.5 ng/mg for all analytes. In cases were homogeneity of variance was not achieved, a weighting factor was applied ( Fig. 1 ). The linear correlation coefficient ranged from R = 0.9226 to R = 0.9998. The matrix effects were acceptable (75-125%) for each analyte (Fig. 2) , and the recovery acceptance criterion (recovery > 50%) was fulfilled for each analyte (Fig. 2 ). Over 77 h, a slight loss of the target analytes was observed, but the maximum loss of peak area was below 25%. In addition, the method was accurate and precise and fulfilled the acceptance criteria for repeatability, intermediate precision, and bias ( Fig. 3 ).
Observational Study of Postmortem Cases
Concentrations Detected in Hair
One or more substances were detected in 420 cases. Segmental analysis was possible in 258 of the positive cases. Segmentation was not possible in cases with shorter hair lengths or samples where the proximal end of the hair was not clear because of the condition of the sample, for example, in putrefied cases where the hair was extremely knotted. The cases with positive findings were split in two datasets: group 1, which included only the segmented cases; and group 2, which combined the segmented and nonsegmented cases. The detected concentrations in hair for all analytes and metabolite ratios are displayed in Table 3 (group 1: segmented cases only) and Table 4 (group 2: segmented and non-segmented cases combined). The concentrations of both segments were normalized to the mean value for the segmented cases. The detected concentrations showed wide variation, and the descriptive statistics are presented as percentiles with the median. A metabolite/ parent drug ratio was calculated if possible. Although the substances mianserin, clonazepam, and chlorpromazine were included in the LC-MS/MS method, they had no positive case in the observed population.
Concentrations Detected at Time of Death and in Postmortem Hair
Toxicological findings at the time of death were available for some cases because the case selection included a previous cross-sectional study that investigated the detection of antidepressants and antipsychotics in suicide and non-suicide cases [25] . Table 5 summarizes the number of cases in which a substance was detected in blood, urine, or organ tissue as well as in the analyzed hair sample.
Segmental Analysis
In 258 cases, segmental analysis was conducted using hair segments of 0-2 cm [S1] and 2-4 cm [S2] measured from the proximal end. The results for both segments were compared to identify changes in the pattern of drug use. Figure 4 shows the frequency of decreases and increases of the drug concentrations from [S2] to [S1].
Cases with Bias from Contamination
Contamination from body fluids can lead to artifacts in the analysis of postmortem hair samples [32] . Four cases with high drug levels in hair that possibly have such artifacts are discussed. The toxicological findings from the postmortem blood analyses and hair analyses are displayed in Table 6 .
Discussion
Concentrations Detected in Hair: Meaning and Considerations
Because of the wide range of detected concentrations, the data were classified in percentiles. This approach addresses the variation in concentrations and helps with comparison of positive findings in routine work [6] . Because different hair lengths reflect different time windows [6] , it is preferable to present data collected from samples with comparable hair lengths (i.e., segmented cases). To increase the number of positive cases, we decided to also include non-segmented samples while remaining aware of the implications of the different hair lengths. Fig. 1 Calibration parameters according to GTFCH guideline for the validation of analytical methods [28] : weighting factor, (R) correlation factor, (LOD) limit of detection, (LOQ) limit of quantification, and linear range (ng/mg) expressed as yellow bar A review of published hair concentrations for the different analytes in this study was made [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] . No published data were found for comparison for opipramol, trimipramine, fluvoxamine, O-desmethylvenlafaxine, benperidol, pipamperone, fluphenazine, and N-desmethylclozapine. The review revealed an inhomogeneity of detected concentrations due to varying investigated hair lengths, number of cases, and different origins of the sample (postmortal or living individuals). To illustrate this inhomogeneity, the overview for the substance quetiapine is given. The data ranged from investigations of single cases [18, 33] and small groups of living individuals (n = 3, [24] ; n = 10 [15] ) up to 22 postmortal hair samples [16] . The presented concentrations varied between 0.01 [24] and 13 ng/mg [16] . In our dataset, we presented data on quetiapine from 81 cases (see Table 4 ) with a concentration range of 0.003 (minimum)-9.79 ng/mg (maximum). For mirtazapine, there were three publications [18, 24, 33] with data only from single cases, while we could present data from Fig. 2 Parameters for recovery and matrix effects, acceptance criteria as green field according to the GTFCH guideline for the validation of analytical methods [28] : recovery > 50%, matrix effect 75-125% 95 postmortem cases (see Table 4 ). Our findings agree with most of the published literature and extend the knowledge base for analytes that are seldom reported. The inhomogeneity of detected concentrations and the lack of sufficient data illustrates the importance of research in this field. There are several factors that can influence the amount of drug detected in the hair, for example, differences between individuals for hair growth, pigmentation, and cosmetic treatment, and frequency of drug consumption, and drug metabolism [2] . Analytical differences in extraction protocols, sample processing (e.g., cutting or powdering), and sample collection (especially segmentation [49] ) have an influence on the amount of drug Group 1 only contains cases in which the hair sample was 4-cm long and cut into two segments: segment 1 was 0-2 cm from the proximal end, and segment 2 was 2-4 cm from the proximal end. The number of cases is given as n Group 2 contains cases in which the hair sample was segmented (group 1, n = 258) and cases in which no segmentation was possible. Cases with sample hair lengths shorter or longer than 4 cm were also included (n = 152). The number of cases is given as n Information on the detection of the target analytes in blood, urine, or organ tissue taken at autopsy was obtained from a previous publication [25] extracted from the hair matrix [2, 50] . External proficiency testing can help to establish better comparability among the conventional methods [2] but is only available for common drugs of abuse and not for the described substances to date. Therefore, comparison with published data from postmortem hair samples should be undertaken with great care. To achieve better comparability, it is recommended that laboratories establish their own databases [50] . Because of these implications, it is not possible to exactly correlate the amount of a substance ingested with the concentration detected in hair [2, decrease of concentration increase of concentration Fig. 4 The frequency of a decrease or increase of analyte concentration from segment [S2] (2-4 cm) to segment [S1] (0-2 cm) for n = 258 cases with a segmental analysis. The absolute number of cases is displayed as n for each analyte 6, 10, 50]. There have been some useful applications of hair analysis in forensic toxicology and the interpretation of postmortem cases [8] . Preferably, multi-sectional analyses should be undertaken for comparison of different periods to monitor changes in the pattern of substance use over a long time [6, 8] .
Metabolite to Parent Drug Ratios
Differentiation of drug use from external contamination is considered a limitation in hair analysis [32] . It has been proposed that relevant metabolites could be detected to minimize misinterpretation [32] . In the case of cocaine, several proposals have been made for differentiation of use/external contamination because some of its metabolites are also found in cocaine powder [51] . Metabolite ratios have then been useful for interpretation of these results. Wherever possible, we analyzed the metabolite to parent drug ratio (Table 4 ). Such ratios have been rarely reported [34] for the investigated analytes. Table 7 compares our findings for the ratios of nortriptyline/ amitriptyline, Ndesmethyldoxepin/doxepin, and N-desmethylclomipramine/ clomipramine with the findings of Pragst et al. for patients undergoing long-term treatment with tricyclic antidepressants [34] . Our findings were comparable for doxepin and amitriptyline, although our maximum values were higher.
Concentrations Detected at the Time of Death and in Postmortem Hair
The agreement between the concentration detected at the time of death and that detected in the hair sample ranged between full and no agreement ( Table 5 ). In cases with no agreement, it could be shown that these substances were repeatedly been intake in the months prior to death, but not acutely. This knowledge would be inaccessible to the forensic investigation if only blood or urine samples were analyzed because they only reflect the intake in the hours before death. There may be bias here because some analytes had very low detection rates (i.e., < five cases, shown in italic font in Table 5 ). Several factors can lead to such discrepancies. The sensitivities of the applied methods for matrices that reveal acute intake can be a factor if only low levels of the drug are detected. Second, the deceased might have stopped using a non-favorable drug weeks or days before the time of death, but it will still be detectable in hair. Again, this supports the use of hair in postmortem analysis for understanding history of use [8] . Figure 4 shows the proportions of decreases and increases in the concentrations from segment 2 ([S2] 2-4 cm from the proximal end) to segment 1 ([S1] 0-2 cm from the proximal end). A decrease in concentration from segment 2 to segment 1 could indicate reduction of drug intake over at least the last 4 months before the time of death. Such a reduction could be associated with a loss of compliance for intake of a prescribed medication. Conversely, an increase in concentration from segment 2 to segment 1 could indicate an increase in drug intake, which could be associated with the start of drug therapy. According to our results, no substance is more likely to show a trend towards an increase or decrease in concentration. However, there were substances that showed a trend towards an increase or decrease, which should not be overinterpreted since those substances were only detected in a few cases (n < 5).
Segmental Analysis
Interpretation of high concentrations with possible bias from contamination
Although the results from postmortem hair analysis can be very helpful, critical interpretation of the results should be undertaken because false positive results from external contamination are an issue [32] . Postmortal incorporation of drugs into the hair can occur through body fluids (e.g., blood, sweat, or putrefaction fluid) or there can be external contamination from environmental pollution [32] . One mechanism of drug incorporation is via sweat since it is known to contain drugs present in blood [8] . Therefore, excessive sweating during a long agonal phase in the process of dying can also affect the hair concentration. The investigator should be aware of these mechanisms in order to avoid false interpretation of long-term exposure [32] . The results of segmental analysis could indicate contamination if the concentrations are homogenous or consecutive. Taking four cases from the dataset as an example (Table 6) , we want to highlight these issues to encourage other investigators to do the same. Homogenous concentrations can be observed in the results of cases 1 and 2. In case 1, where a woman was found dead in a bathing tub with cuts to her arms, there are extremely high concentrations of citalopram and its metabolite N-desmethylcitalopram in both the segments (136 and 176 ng/mg citalopram; 5.46 and 4.77 ng/mg N-desmethylcitalopram). A lethal concentration of citalopram was found in the postmortem blood sample, and a high amount of citalopram was found in the stomach contents. In addition, the ratio of the metabolite to the parent drug (0.033; Table 6 ) is one-tenth that of the mean ratio for the whole dataset of segmented cases (0.334; Table 3 ). Similar results are observed for doxepin and its metabolite in case 2 with a N-desmethyldoxepin/doxepin ratio of 0.018 (Table 6 ) and a mean ratio of 1.36 for all the segmented cases (Table 3) . Furthermore, in case 2, the concentrations of citalopram, doxepin, melperone, trimipramine, and sertraline are high and homogenous throughout the two segments, and these substances were found in lethal concentrations in the blood samples. Mirtazapine and fluoxetine were not found in the postmortem blood but were detected in high levels in hair.
Therefore, external contamination is not likely and these results could point to long-term exposure to mirtazapine and fluoxetine. However, even if, in the presented cases, potentially lethal blood concentrations have been found, a contamination also occurs with lower blood concentrations. Therefore, a lethal blood concentration may be not a criterion for a possible contamination. The scenario of case 1, a body in a bathtub filled with water and blood from wounds of the descendant, is an example how hair can be contaminated. Case 3 shows a different result constellation with high concentrations in the first segment for all substances and concentrations in the second segment that are about half those in the first segment. Lethal blood concentrations were found for all these substances. The phenomenon of axial diffusion throughout segments, described by Kintz et al. [52] , should also be considered. Other authors [13, 17] have proposed that internal contamination of distal segments can occur from sweat/sebum or aggressive hair treatment. Differences in hair growth or alignment of hair during cutting can also affect the concentrations in neighboring segments [24, 49] . Finally, case 4 illustrates the discussed issues for a sample with no segmentation, which, in this case, was because of the short hair length (1.5 cm). In this Cases with high drug concentrations in hair are shown. The results of the postmortem hair analyses are compared with the concentrations of the same analytes found in blood and the stomach contents case, high levels of chlorprothixene, trimipramine, and doxepin were observed in the hair, and these substances were found in the postmortem blood. The ratio of doxepin and its metabolite (N-desmethyldoxepin/doxepin = 0.07; Table 6 ) is much lower than the mean ratio for all the segmented cases (1.36; Table 3 ). This may indicate a mechanism of contamination that is not detectable without segmentation. In comparison with the concentration detected in case 4, some studies have found lower concentrations for chlorprothixene (mean 0.38 ng/mg) [17] , and others have found similar concentrations (30 ng/mg) [23] . This difference is difficult to interpret because of the lack of data available on antidepressants and antipsychotics in general. The data from these four cases was not removed from the datasets in Tables 3 and 4 since contamination could only be assumed. Furthermore, the presentation in percentiles allows the interpretation of high hair concentrations.
Limitations and Strengths
A comprehensive and sensitive method for the determination of 52 analytes was developed and successfully validated according to the guidelines of the GTFCh [28] . The method showed excellent sensitivity with low limits of detection (pg/ mg range), selectivity, accuracy, and stability. The major limitation of the presented data is the postmortem origin of the hair samples. Besides the lack of information on hair treatment, exact information on drug exposure (e.g., dose and duration of intake) is rarely available in postmortem cases; therefore, quantitative data from postmortem cases cannot be used to discriminate if there was constant or sporadic exposure. Kintz et al. [32] described the influence of external contamination from body fluids or environmental contamination in postmortem toxicology and its risk of false-positive interpretations of long-term exposure to drugs. Since a segmentation was not possible in all cases, two datasets were presented. The samples in the second dataset were a mix of hair lengths shorter and longer than 4 cm, which introduces bias because the window of detection depends on the hair length [2] . Other authors [17] have published results with similar bias from varying hair lengths and presented the concentrations as averages [16] . A review of the published literature shows that variation in investigated hair lengths is common, and length limitations should be considered when comparing data to avoid false interpretations.
The presented data are informative and valuable for numerous drugs in postmortem hair and may be helpful in future casework when interpreted carefully. To the best of our knowledge, this study is the first that presents postmortem hair concentrations of antidepressants, antipsychotics, and benzodiazepines in such a comprehensive way. An overview of the literature revealed that our data are comparable with the work of other authors in some areas but extend the field of knowledge for many analytes. Furthermore, we have presented metabolite ratios for eight analytes that could be helpful in differentiation between drug use and external contamination. We have discussed cases from acute intoxication in the light of the issue of external contamination in postmortem hair analysis and considered how it could be addressed by segmental analysis.
Conclusions
The main aim of this work was to validate a sensitive method for detection of 52 analytes (antidepressants, antipsychotics, and benzodiazepines) in hair and to apply it to preselected postmortem cases, which could help correct the lack of comprehensive data on postmortem hair concentrations for drugs other than drugs of abuse. In accord with previous work, our informative study presents quantitative data for 49 substances in hair samples from 420 postmortem cases. These data can help in the assessment of certain case constellations when interpreted carefully and with an emphasis on exclusion of The metabolite/parent drug ratios found in group 2 (n = 420 for segmented and non-segmented cases combined) are compared with those from the work of Pragst et al. [34] false positive results from external contamination. We have addressed these important issues, which should be considered by forensic investigators, in four example cases. Postmortem hair analysis can have further applications such as proof of repetitive exposure, proof of administration, or use as a tool for exclusion of exposure [8] . If the frequency of detected drugs per case reveals multi-exposure to drugs, it should be considered as a history of changing treatment regimens as a result of low efficiency or bad compliance. Retrospective toxicological data from postmortem cases can be valuable in risk assessment and the search for better treatment strategies [53] .
